We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.ORDINARY SHARE PURCHASE AGREEMENTOrdinary Share Purchase Agreement • April 11th, 2022 • Stealth BioTherapeutics Corp • Pharmaceutical preparations • Delaware
Contract Type FiledApril 11th, 2022 Company Industry JurisdictionThis ORDINARY SHARE PURCHASE AGREEMENT (“Agreement”) is made as of April 10, 2022 (the “Effective Date”), by and between Stealth BioTherapeutics Corp, a Cayman Islands exempted company (the “Company”), and Morningside Venture (I) Investments Limited (the “Investor”).
ORDINARY SHARE PURCHASE AGREEMENTOrdinary Share Purchase Agreement • April 13th, 2020 • Stealth BioTherapeutics Corp • Pharmaceutical preparations • Delaware
Contract Type FiledApril 13th, 2020 Company Industry JurisdictionThis ORDINARY SHARE PURCHASE AGREEMENT (“Agreement”) is made as of April 10, 2020 (the “Effective Date”), by and between Stealth BioTherapeutics Corp, a Cayman Islands exempted company (the “Company”), and Morningside Venture (I) Investments Limited (the “Investor”).
ORDINARY SHARE PURCHASE AGREEMENTOrdinary Share Purchase Agreement • October 10th, 2019 • Stealth BioTherapeutics Corp • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 10th, 2019 Company Industry JurisdictionThis ORDINARY SHARE PURCHASE AGREEMENT (“Agreement”) is made as of October 10, 2019 (the “Effective Date”), by and between Stealth BioTherapeutics Corp, a Cayman Islands exempted company (the “Company”), and Alexion Pharmaceuticals, Inc., a Delaware corporation (the “Investor”).